Scientific activity and scientific production
"Cima's scientific activity has generated publications in journals of high scientific impact, patented biomedical inventions and coordination in international projects."
GLORIA GONZÁLEZ ASEGUINOLAZA
DEPUTY DIRECTOR. CIMA UNIVERSIDAD DE NAVARRA
Scientific production in data
During 2021, Cima's scientific activity recorded a total of 261 publications in high impact journals.
261
scientific publications in total
211
scientific publications
in the first quartile
11,80
average impact factor
with authorship
Our research results in high impact journals
Scientific activity of the
Cima Universidad de Navarra
Latest scientific publications
- New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study Apr 19, 2024 | Magazine: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models Mar 31, 2024 | Magazine: Neuro-Oncology
- An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial) Mar 13, 2024 | Magazine: International Journal of Gynecological Cancer
- Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer Mar 2, 2024 | Magazine: European Journal of Cancer
Hepatology: Liquid Biopsy and Carcinogenesis
Active
PID2022-137181OB-I00 Characterization of SLU7 proteome and interactome and their rewiring in carcinogenesis: from epigenetics to protein stability (SLUTOME)
Cima Principal Investigator:
Carmen Berasain Lasarte
Translational Oncology
Active
The innate immune system as a therapeutic target in lung tumors resistant to immunotherapy based on PD-1/PD-L1 blockade
Cima Principal Investigators:
Rubén Pío Osés, Daniel Ajona Martínez-Polo
Funder:
Instituto de Salud Carlos III
Award year
2023
DNA and RNA Medicine
Active
MCI PID2022-137327OA-I00 IntegrAAV
Cima Principal Investigator:
Carmen Unzu
Funder:
Ministerio de Ciencia, Innovación y Universidades
Therapeutic Non-Coding RNA, Microproteins and Integrated Stress in Cancer
Active
Rational to modulate the Microbiome-induced Endoplasmic Reticulum stress as tool to avoid the immune evasion in Hepatocellular Carcinoma (RETO)
Cima Principal Investigator:
Josepmaría Argemí
Funder:
Ministerio de Ciencia, Innovación y Universidades